Basilea announces change in its management structure

11-Oct-2011 - Switzerland

Basilea Pharmaceutica Ltd. announced that Ronald Scott has been appointed Chief Operating Officer (COO) of Basilea Pharmaceutica International Ltd.

Ronald Scott was appointed Chief Financial Officer at the company's inception. In addition to finance, business development, investor relations and public relations, he now assumes responsibility for commercial activities, manufacturing and corporate services with the respective departments retaining their heads. He will continue as ad interim Chief Financial Officer. In line with Basilea's strategic focus to bring innovative new drugs to the market, research and development, including Basilea's operations in China, will continue to report directly to Chief Executive Officer, Dr. Anthony Man.

Other news from the department people

More news from our other portals

So close that even
molecules turn red...